BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9826370)

  • 21. IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.
    Logerot S; Figueiredo-Morgado S; Charmeteau-de-Muylder B; Sandouk A; Drillet-Dangeard AS; Bomsel M; Bourgault-Villada I; Couëdel-Courteille A; Cheynier R; Rancez M
    Front Immunol; 2021; 12():614115. PubMed ID: 33717097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
    Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
    J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.
    Kozlowski PA; Cu-Uvin S; Neutra MR; Flanigan TP
    Infect Immun; 1997 Apr; 65(4):1387-94. PubMed ID: 9119478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.
    Wassen L; Jertborn M
    Clin Vaccine Immunol; 2006 Feb; 13(2):202-7. PubMed ID: 16467326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses.
    Kato H; Bukawa H; Hagiwara E; Xin KQ; Hamajima K; Kawamoto S; Sugiyama M; Sugiyama M; Noda E; Nishizaki M; Okuda K
    Vaccine; 2000 Jan; 18(13):1151-60. PubMed ID: 10649615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.
    Quiding M; Nordström I; Kilander A; Andersson G; Hanson LA; Holmgren J; Czerkinsky C
    J Clin Invest; 1991 Jul; 88(1):143-8. PubMed ID: 1905327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
    Yao XY; Yuan MM; Li DJ
    Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.
    Bergquist C; Johansson EL; Lagergård T; Holmgren J; Rudin A
    Infect Immun; 1997 Jul; 65(7):2676-84. PubMed ID: 9199436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues.
    Imaoka K; Miller CJ; Kubota M; McChesney MB; Lohman B; Yamamoto M; Fujihashi K; Someya K; Honda M; McGhee JR; Kiyono H
    J Immunol; 1998 Dec; 161(11):5952-8. PubMed ID: 9834076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination.
    Friman V; Quiding M; Czerkinsky C; Nordström I; Larsson L; Ericson D; Björkander J; Theman K; Kilander A; Holmgren J
    Clin Exp Immunol; 1994 Feb; 95(2):222-6. PubMed ID: 8306495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
    Staats HF; Nichols WG; Palker TJ
    J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract.
    Gockel CM; Bao S; Beagley KW
    Mol Immunol; 2000 Jun; 37(9):537-44. PubMed ID: 11163403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rectal immunization for induction of specific antibody in the genital tract of women.
    Crowley-Nowick PA; Bell MC; Brockwell R; Edwards RP; Chen S; Partridge EE; Mestecky J
    J Clin Immunol; 1997 Sep; 17(5):370-9. PubMed ID: 9327336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue.
    Bergmeier LA; Tao L; Gearing AJ; Adams S; Lehner T
    Adv Exp Med Biol; 1995; 371B():1567-73. PubMed ID: 7502858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
    Klavinskis LS; Barnfield C; Gao L; Parker S
    J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
    Gallichan WS; Rosenthal KL
    Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen.
    Lehner T; Tao L; Panagiotidi C; Klavinskis LS; Brookes R; Hussain L; Meyers N; Adams SE; Gearing AJ; Bergmeier LA
    J Virol; 1994 Mar; 68(3):1624-32. PubMed ID: 8107223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
    Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
    J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans.
    Rudin A; Johansson EL; Bergquist C; Holmgren J
    Infect Immun; 1998 Jul; 66(7):3390-6. PubMed ID: 9632610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.